Advanced Testing and Monitoring For my patients with known or suspected hemochromatosis, I recommend comprehensive testing that goes beyond basic iron studies, including the approach I detail in my article on assessing your total toxic burden: Oxidative Stress Markers: Lipid peroxidation markers (malondialdehyde, F2-isoprostanes) Antioxidant enzyme levels (superoxide dismutase, catalase, glutathione peroxidase) Total antioxidant capacity Genetic Testing: Complete HFE genotyping (C282Y, H63D, S65C variants) Antioxidant enzyme genetic variants Detoxification pathway genetic analysis Comprehensive Toxin Assessment: Given the connection between iron overload and increased susceptibility to other environmental toxins, I often recommend testing for mycotoxins, heavy metals, and environmental chemicals as discussed in my toxic load assessment protocols
Neurodegenerative disorders Ferroptosis has been implicated in various neurodegenerative disorders, including Alzheimers disease (AD), Parkinsons disease (PD), and Huntingtons disease (HD)
BPC-157 + TB-500 The BPC-157/TB-500 blend combines two regenerative peptides that appear to work better together than alone
5-Amino-1MQ blocks NNMT, which in preclinical models frees up more of that precursor and lifts NAD+ inside fat tissue
Any temperature excursion above 8C causes irreversible protein denaturation that eliminates bioactivity without visible degradation
A certificate should state whether the reported quantity is calculated as free emideltide, the complete acetate-associated material or another defined form
